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Abstract
Brazilein performs anti­cancer activities on several cancer cells and potentially inhibits metastasis.
The aims of this study is to observe the synergistic cytotoxic and migration inhibitory effect of brazilein
combined with cisplatin on 4T1 breast cancer cells. Under MTT assay, we found that brazilein revealed
cytotoxic effect on 4T1 cells in a dose­dependent manner (IC50=50 ± 0.3 µM). Combination of brazilein
and cisplatin showed synergistic effect (CI=0.72). Flowcytometry analysis on the cell cycle progression
showed that single treatment of 25 µM brazilein induced G2/M­phase accumulation, 12.5 µM cisplatin
induced S­phase accumulation, while combination of brazilein and cisplatin induced S­phase and G2/M­
phase accumulation. Combination of brazilein and cisplatin induced apoptosis higher than that of the
single treatments. Based on wound healing assay, 12.5 µM brazilein and its combination with 6.25 µM
cisplatin inhibited cells migration. Immunoblotting and gelatin zymography analysis showed that
combination of brazilein and cisplatin inhibited the expression level of Rac1 and MMP9 proteins. Based
on these results, we conclude that brazilein enhanced cytotoxic activity of cisplatin and inhibited migration
on 4T1 cells and potentially can be developed as an enhancing cytotoxic and antimetastasis agent.
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Introduction
Brazilein (Figure 1), a major compound
of Caesalpinia sappan L., performs potential
antiproliferative effect on several cancer cells.
In vitro studies have proven that brazilein
exhibit cytotoxic activities and apoptosis
induction on MCF­7, T47D, and other breast
cancer cell lines (Tao et al., 2011, 2013). These
cytotoxic activities are mediated through
aberration of some signal transduction,
mainly on MAP Kinases signaling pathways
(Hsieh et al., 2013). In many cancer cells,
MAPKs involve on cancer cell growth and
metastasis (Hanahan and Weinberg, 2011).
Therefore, the physiologically­targeted
mechanism of brazilein as anti­cancer on some
specific cancer cells need to be explored.
Strategy on cancer treatment is not only
focused on one target mechanism, but it
should be developed on several target
mechanism. On the other hand, cancer
progression usually involve aberration of cell
proliferation and cell migration as well as
invasion (Kemper et al., 2014). The 4T1 cell is
the example of metastatic breast cancer that
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Figure 1. Chemical structure of brazilein (Laksmiani et
al., 2015)
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performs active proliferation, migration and
invasion (Kaur et al., 2012). Some growth
signaling involve in the 4T1 cells proliferation
including activation of NF­κB transcription
factor (Tsubaki et al., 2013). Our previous
research performs that brazilein inhibits
proliferation on MCF­7 breast cancer cells via
inhibition of NF­κB activation (unpublished
data). Hsieh et al., (2013) reported that
brazilein inhibits NF­κB activation leading
to inhibition of migration on MDAMB­231
cells. Since NF­κB activation usually increase
the side effect of chemotherapeutic agent such
as cisplatin and doxorubicin, therefore the
exploration of reduction of side effect through
NF­κB signaling is needed to be explored.
Our previous study showed that brazilein
inhibits doxorubicin resistant­MCF­7 cancer
cells growth (Laksmiani et al., 2015). In this
regards, Brazilein has a potential effect to be
developed as co­chemotherapeutic agent
against cisplatin as well as doxorubicin.
Cell migration and invasion are
indispensable of the metastasis process.
Tumor metastasis is a complex process that
allows the tumor cells grow on a variety of
other tissues and organs. Metastasis occur
when tumor cells shed from a primary tumor
cells by damaging the extracellular tissues,
migrate, invade surrounding tissue, enter the
bloodstream and reach the target of a certain
tissue to form secondary tumors (Brooks et
al., 2010). Cisplatin (CDDP) is one of the first
line therapy in metastatic triple negative
breast cancer (Zhang et al., 2015). Surprisingly,
low concentration of cisplatin induces
epithelial­to­mesenchymal transition (EMT)
and followed by increasing instead of
inhibiting of cancer metastasis (Latifi et al.,
2011). On the other hand, brazilein suppresses
cancer cells migration and invasion on
MDAMB­231 cells (Hsieh et al., 2013). It is
interesting to know whether brazilein
performs a potential effect to inhibit cisplatin
induced­migration and invasion on 4T1 cells.
NF­κB plays a role on cell proliferation
and metastasis through the activation of
targeted gene expression such as MMP9 and
MMP2 (Hsieh et al., 2013; Kim, 2010). The 4T1
cells also performs such of this phenomenon
(Amin et al., 2015). Matrix metalloproteinases
(MMPs) belong to a family of zinc­dependent
endopeptidases, highly conserved and
structurally related, capable of degrading
many components of basement membrane
and extracellular matrix (ECM). The active
MMPs bind with membrane molecules and
degrade ECM (Hua et al., 2011). Brazilein
inhibits MMP2 protein in both its expression
and activation on MDAMB­231 cells (Hsieh
et al., 2013). On the other hand, cisplatin
induces migration mediated by inducing of
Rac1 protein expression (Geng et al., 2016).
The Rac1 protein is a member of RHO family
of small GTPase that plays a role in neoplastic
transformation, tumor progression and
metastasis. Activation of p120/Vav2 and PI3K
pathways activate Rac1 protein leading to
lamellipodia formation through ASP­family
verprolin­homologous proteins (WAVEs) and
p21­activated kinases (PAK1) activation
(Ridley, 2015; Valls et al., 2012). Our main
purpose of this study is to explore the
cytotoxic and antimetastasis potential of
brazilein focusing on inhibiting of migration
through inhibition of Rac1 and MMP9 protein
expression on 4T1 cells.
Materials and Methods
Samples
Brazilein (Be) isolated from Caesalpinia
sappan L. was obtained from Cancer
Chemoprevention Research Center (CCRC),
Faculty of Pharmacy, Universitas Gadjah
Mada. Cisplatin (CDDP) was purchased from
Sigma (P­4394).
Cell culture
4T1 metastatic cell line (ATCC CRL­
2539) was kindly given by Prof. Dr. Mashashi
Kawaichi (NAIST) and was cultured in
Dulbecco's Modified Eagle Medium (DMEM)
medium (Gibco) with 10% Fetal Bovine Serum
(Gibco), 1.5% Penicillin­Streptomycin (Gibco)
and 0.5% fungizone (Gibco).
Cytotoxic assay
4T1 cells in 96­well plates with 104
cells/well were treated with various
concentration of treatment groups. After 24
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h incubation, culture medium was removed
and cells were washed in PBS (Sigma). Then,
cells were incubated with 100 µL culture
medium and 10 µL MTT (Sigma) 5 mg/mL
in every well for 4 h. MTT reaction was
stopped by SDS reagent (10% Sodium dodecyl
sulphate (Merck) in 0.01 M HCl (Merck)) and
was incubated overnight. The absorbance
was measured by ELISA reader (Bio­Rad) at
wave length of 595 nm.
Cell cycle assay
Propidium iodide (PI) staining kit
(Becton Dickinson) was used to analyze DNA
content. Cells were seeded in 24­well plates
with 5x104 within 24–48 h. Cells were treated
with various concentration of samples in
single and combination. After a 24 h
treatment, cells were harvested, and the cells
were resuspended in PBS, fixed with 70%
ethanol, labeled with PI (2 µg/mL), and
incubated at room temperature in the dark
for 10 min. DNA content was analyzed using
a flow cytometry (Becton Dickinson) and
followed by flowing software (version 2.5.1).
Apoptosis assay
Apoptotic population was determined
by PI­Annexin V assay (Annexin V­FITC
Apoptosis Detection Kit Roche). Cells were
seeded in 24­well plates with 5x104 within
24–48 h. Cells were treated with various
concentration of samples in single and
combination. After a 24 h treatment, cells
were harvested, added with 1x binding buffer,
labeled with PI­Annexin V, and incubated at
room temperature in the dark for 5 min. Then
the cells suspension was analyzed using a
flow cytometry (Becton Dickinson).
Wound healing assay
Cells were seeded in each well of 24­
well plate with 1×105 cells and incubated at
37°C in CO2 incubator for 24 h. Thereafter cell
were starved by using serum free­medium
(containing 0.5% fetal bovine serum) for 24
h. The confluent cell monolayers were
wounded by a yellow­tip. After washing once
with PBS, the cells were added with DMEM
culture medium which contained of 1/4 IC50
of samples in single and combination. Time­
lapse images were acquired at 18, 24 and 42
h. Percent of closured were analyzed by using
Image­J software.
Gelatin zymography assay
MMP­9 activity was assayed by gelatin
zymography. Cells were seeded in each well
of 6­well plate with 1×106 cells and incubate
at 37°C in CO2 incubator for 24 h. Cells were
incubated with 1/4 IC50 of samples in single
and combination in serum free­medium for
24 h. The supernatants were collected and
subjected to gel electrophoresis on 10%
running gel containing 0.1% gelatin. The gel
were washed in renaturing solution containing
2.5% Triton x­100 for 30 min, and followed
by incubation for 20 h at 37°C with incubation
buffer. The gels were stained for 30 min in
0.5% coomassie brilliant blue and then
destained with destaining solution (10% v/v
methanol and 5% v/v acetic acid). Gel were
scanned and analyzed with image­J software.
Immunoblotting assay
Cells were seeded in 10 cm cultured
dish with 1×106 cells and incubated at 37°C
in CO2 incubator for 24 h. Cells were incubated
with ¼ IC50 of samples in single and
combination for 24 h. Cell were collected with
RIPA buffer (25 mM Tris­HCl at pH 7.6, 150
mM NaCl, 1% NP­40, 1% deoxycholic acid­
Na, 0.1% SDS, protease and phosphatase
inhibitor cocktail). Protein samples were
obtained using Bradford method and were
measured by microplate reader (SH­1000,
Corona electric), separated by electrophoresis
on 7–15% SDS polyacrylamide gel
electrophoresis (PAGE) gels, and electro­
transferred onto PVDF transfer membranes
(Immobilon, millipore). After blocking with
1x NET gelatin, the membranes were probed
with antibodies for Rac1 (33186, Abcam), p120
(sc­13957) and ß­actin (sc­47778, Santa Cruz
Biotechnologies, Santa Cruz, CA), and then
exposed to horseradish peroxidase (HRP)­
conjugated secondary anti­mouse (sc­2031,
Santa Cruz Biotechnologies, Santa Cruz, CA)
or anti­rabbit antibodies (7074P2, Cell
signaling). Protein expression was examined
using the enhanced chemiluminescence (ECL)
system (Amersham).
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Statistical analysis
Parameter of inhibitory concentration
(IC50) and combinatory index (CI) were
measured based on the previous reports
(Mosmann, 1983; Reynolds and Maurer, 2005).
The IC50 values of three independent
experiments were expressed as mean ±
standard deviation (SD). Analysis of
significantly between control/untreated group
and treated groups were analyzed by unpaired
Student’s t­test (Microsoft Excel 2013). Mean
differences was significant at the P<0.05.
Results
Brazilein and cisplatin performed synergistic
effect on 4T1 cells
The confirmation of the cytotoxic
activity of brazilein is important to be
established as a basic anti­cancer performance
and to be developed for the other anti­cancer
activities. We used MTT assay as a standard
method to measure the cytotoxic activity.
After 24 h treatment, brazilein and cisplatin
performed cytotoxic activities in a dose­
dependent manner with IC50 values of 50 ±
0.3 µM and 26 ± 0.5 µM, respectively
(Fig.2A–B). Furthermore, to confirm whether
the compound affects on cytotoxic of cisplatin,
we carried out combination treatment with
series of concentrations under IC50 value. The
synergistic combination was measured by
combination index (CI) parameter. The result
showed that combination of 1/10, 1/8, ¼,
and ½ IC50 of brazilein and cisplatin exhibited
synergistic effect on inhibition of 4T1 cells
growth with CI values less than 1 (Fig. 2C–D).
The combination of ½ IC50 of brazilein and
cisplatin inhibited cell viability by 62%. These
results showed that brazilein possessed
cytotoxic activity on 4T1 cells with a middle
intensity but potential to be developed as co­
chemotherapeutic agent. Whereas the
combination treatment showed that brazilein
increased the sensitivity of 4T1 cells upon
cisplatin treatment. The cytotoxic activity of
brazilein in single and combination with
cisplatin may occur due to inhibition of cell
cycle modulation or apoptosis induction.
Thus, we conducted experiments to observe
the cell cycle modulation and apoptosis event
Figure 2. Cytotoxic effect of single treatment of brazilein and its combination with cisplatin on 4T1 cells. Cells were
treated with various concentration of samples as indicated in the figure for 24 h and subjected for MTT assay. A.
Brazilein (1–150 µM), B. Cisplatin (5–60 µM), C. Combination of brazilein­cisplatin (1/10–1/2 IC50), D. The CI value
of combination of brazilein­cisplatin. Error bar means standard deviation (n=3; *P<0.05, Student’s t­test).
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upon treatment with brazilein and cisplatin.
Combination of brazilein and cisplatin
induced cell cycle arrest on 4T1 cells.
To observe the specific mechanism of
brazilein and its combination with cisplatin
on inhibition of cell cycle progression, we
analyze the cell cycle profiles after treatment
of samples for 24 h by using flow cytometry.
The results indicated that single treatment of
1/2 IC50 of brazilein caused sub­G1 and
G2/M­phase accumulation (Fig. 3B, 3E), while
cisplatin caused S­phase accumulation (Fig.
2C, 2E) compared to untreated cells (Fig. 3A,
3E). The combination of brazilein and
cisplatin (1/2 IC50) increased the cells
accumulation in S­phase and G2/M­phase
(Fig. 3D–E). Furthermore, these data showed
that the cytotoxic activity of brazilein in single
and in combination with cisplatin induced
sub­G1. These phenomena suggested that the
treatment of brazilein in single and in
combination with cisplatin may induce cell
death.
Combination of brazilein and cisplatin
induced apoptosis on 4T1 cells.
Next, we observed the effect of brazilein
in single and in combination with cisplatin
on apoptosis induction. Apoptosis is a
programmed physiological event leading to
cell death that involving the changing of
membrane dynamic, nuclear fragmentation
and usually become necrosis at the end
(Ouyang et al., 2012). Therefore, to examine
the phenomenon of brazilein and its
combination with cisplatin on apoptosis
induction we performed PI­anexin V staining
by using flow cytometry. The result showed
that single treatment of 25 µM brazilein and
12.5 µM cisplatin exhibited total apoptosis
(early and late apoptosis) up to 19% and 13%
respectively (Fig. 4B,4C,4), while combination
of brazilein and cisplatin exhibited total
apoptosis up to 30% (Fig. 4D–E) and increase
the necrotic cells. These data suggested that
combination of brazilein and cisplatin
increased cells death compared to the single
treatments on 4T1 cells.
There are internal and external
molecular event in metastasis processes.
Internal molecular signaling during migration
process involves actin polymerization and
lamellipodia formation. This event mainly
Figure 3. The effect of single treatment of brazilein and
its combination with cisplatin on cell cycle profiles on
4T1 cells. Cells were treated with vehicle (A), 25 µM
brazilein (B), 12.5 µM cisplatin (C), and combination of
brazilein­cisplatin (D) for 24 h, stained with PI and
analyzed by using flow cytometry according to the
method and quantified by using flowing software (E).
Figure 4. The effect of single treatment of brazilein and
its combination with cisplatin on apoptosis induction
on 4T1 cells. Cells were treated with vehicle (A), 25 µM
brazilein (B), 12.5 µM cisplatin (C), and combination of
brazilein­cisplatin (D) for 24 h, stained with PI­Annexin
V and analyzed by using flow cytometry according to
the method and quantified by using flowing software (E).
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induce by the expression and activation of
Rac1 and p120 (Valls et al., 2012). On the other
hand, cancer progression is also marked by
highly expression of proteinases in the
microenvironment such as MMP9 to impair
ECM (Hua et al., 2011). Therefore, to confirm
whether the mechanism underlying migration
inhibition of brazilein, we performed gelatin
zymography to analyze the level of MMP9
in the environment and immunoblotting
experiment to analyze the level of Rac1 and
p120 protein in the cells. The level of MMP9
in the medium of 4T1 cells was decreased in
response to treatment 12.5 µM brazilein and
its combination with 6.25 µM cisplatin (Fig.
6A–B). Single treatment of 6.25 µM cisplatin
did not significantly reduce the MMP9 level
suggested that the decreasing of MMP9 level
in the combination treatment was due to
brazilein. Furthermore, brazilein and its
combination with cisplatin decreased Rac1
protein expression but not p120 in the 4T1
cells (Fig. 6B).
Discussion
The 10 hallmarks of cancer noted that
cell cycle modulation, apoptosis induction,
and inhibition of metastatic stages of cancer
become important targets in cancer therapy
development (Hanahan and Weinberg, 2011).
In this report, we present the effect of brazilein
on several physiological targets on cancer
development, especially on metastatic breast
cancer cells. We used 4T1 cells line that has
been recognized as active cells in proliferation
and migration (Kaur et al., 2012).
Comprehensively, we found that brazilein
exhibited middle or low cytotoxic effect, cell
cycle modulation, apoptosis induction, and
inhibition of cells migration. These results
supported our previous data and other results
reported elsewhere (Hsieh et al., 2013;
Laksmiani et al., 2015; Tao et al., 2011, 2013).
Our data give additional information
concerning on the physiological effects of
brazilein in single and in combination with
cisplatin on a progressive cell line, 4T1.
In this study, we showed that brazilein
performed cytotoxic effect to 4T1 cells with
IC50 value of 50 ± 0.3 µM. This cytotoxic value
is categorized as low level according to
Larsson et al. (2006). Functional food such as
Caesalpinia sappan L. commonly safe and less
toxic on cells (Nirmal et al., 2015).
Figure 5. The effect of single treatment of brazilein and its combination with cisplatin on 4T1 cells migration. Cells
were scratched according to wound healing assay, were treated with 12.5 µM brazilein and 6.25 µM cisplatin in
single and in combination, were photographed at 0, 18, 24, and 42 h, then analyzed by using image J software. A.
Wound closured, B. Relative wound closured after 42 h samples treatment. Error bars mean standard deviation (n
= 3, *P<0.05, Student’s t­test).
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Nevertheless, we should consider when we
consume this plant in high consumption
because brazilein is the major compound in
this plant. However, the synergistic effect
with cisplatin in enhancing cytotoxicity on
the cells gives insight for the use of brazilein
to enhance the chemotherapeutic effect (the
efficacy) and to reduce the side effect of
cisplatin. Even we still do not know the
molecular mechanism underlying this
synergistic effect, but at least we have
information that lower concentration of
cisplatin gave the same cytotoxic effect to the
cells when it combined with brazilein. This
phenomenon also performed by brazilein in
combination with doxorubicin which
sensitized MCF­7 resistant doxorubicin cancer
cells (Laksmiani et al., 2015), thus, gives good
prospect of brazilein to be developed as co
chemotherapeutic agent. However, this data
are the in vitro report and should be
confirmed with in vivo experiment.
The shift of cell cycle profile in
combination treatment of brazilein­cisplatin
is an interesting finding in this study. Based
on the cell cycle profiles, brazilein showed
different mechanism compare to cisplatin.
Cisplatin is well known to induce cell cycle
arrest at S­phase (Shen et al., 2013) and our
finding showed the same phenomenon.
However, brazilein induced cell
accumulation in G2/M phase. This
phenomenon is similar with the effect of
brazilin (the reduced form of brazilein) that
induces cell accumulation in G2/M phase on
myeloma U266 cells (Kim et al., 2012).
Moreover, the different shifting of cell cycle
profiles between cisplatin and brazilein
indicated the differences targets of the two
compounds, especially on the cell cycle
regulation that should be investigated
further. The differences of the targets
mechanism are important to potentiate the
cytotoxic effect to the cancer cells (Chou,
2006). In this regards, we confirmed that the
combinational treatment of both compounds
gave synergistic effect to inhibit cells growth
by > 50% (Fig. 2C–D). Our data also showed
that brazilein pulled the cells into sub­G1
phase indicated that this compound induces
cell death or apoptosis. However, the
combination treatment seemed to reduce the
cell death (decrease the sub­G1 phase by 4%).
This decreasing of the sub­G1 accumulation
may be due to most of the apoptotic cells
underwent necrosis. This phenomenon was
confirmed by PI­annexin V staining under
flocytometry assay (Fig. 4D–E). Apoptosis
leading to necrosis is the normal
phenomenon in in vitro studies of cell death
due to the absent of the phagocytic cells
(Ouyang et al., 2012). Our result suggested
that the combination treatment of brazilein
and cisplatin enhanced cell cycle arrest and
accelerated the apoptosis evidence.
Brazilein was reported to inhibit
migration and invasion in MDAMB­231
breast cancer cells (Hsieh et al., 2013).
Metastasis is a fatal state of cancer
progression, which needs migration and
Figure 6. The effect of single treatment of brazilein and
its combination with cisplatin in MMP9 and Rac1
protein level in 4T1 cells. Cells were treated with 1/4
IC50 of single and combination of brazilein and cisplatin
for 24 h and were observed by gelatin zymography and
immunoblotting assay. A. Graphic of MMP9 protein
level. B. p120 and Rac1 protein level of samples on 4T1
cells. Analysis of protein level of MMP9 was calculated
by using ImageJ software. Error bars mean standard
deviation (n = 3, *P<0.05, Student’s t­test).
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invasion to initiate the process. Targeted
therapy to inhibit those two processes would
be beneficially for triple negative cancer cells
treatment that have characteristic of highly
metastasis (Ferrari­Amorotti et al., 2014;
Martin et al., 2013). The present data showed
that brazilein, in single and in combination
with cisplatin inhibited cells migration (Fig.
5) of 4T1 cells. Furthermore, we observed that
single treatment of brazilein and its
combination with cisplatin suppressed Rac1
protein expression (Fig. 6B). Rac1 is a member
of Rho­GTPase family which plays an
important role in lamellipodium extension
together with cdc­42 and Rho­A (Ridley,
2015). Previously, Chen et al., (2014) reported
that curcumin inhibits activation of PAK1,
the downstream of Rac1, mediated by
suppression of Rac1 protein expression.
Flavonoid wogonin inhibits Rac1 expression
as well as other Ras and activated ERK and
PI3K/Akt pathway (Zhao et al., 2014).
Upregulation of Rac1 activity is mediated
through several signaling pathways
including Wnt stimulation that involving
binding of p120­catenin with Rac1 and Vav2
(Valls et al., 2012). However, our finding (Fig.
6B) did not show any significance difference
of p120­catenin expression among treated
and untreated cells. This phenomenon
indicated that the cells migration inhibitory
effect of brazilein was due to other Rac1
activation mechanism such as PI3K kinase
pathway. Kim et al. (2014) reported that
rhapontigenin and the PI3K inhibitor
wortmannin reduces Rac1 activation in
MDAMB­231 cells through inhibition of
PI3K­dependent Rac1 signaling pathway.
The MMPs family is important in the
invasion step of metastasis to degrade the
extra cellular matrix, and among them, MMP9
and MMP2 are known to be highly expressed
in metastatic breast cancer cells (Hua et al.,
2011). Our study demonstrated that brazilein
and its combination with cisplatin decreased
the gelatinolytic activity of MMP9 protein in
4T1 cells (Fig 5A­B). It was reported by Hsieh
et al. (2013) that brazilein inhibits nuclear
translocation of NF­κB protein, thus,
suppressing the NF­κB signaling pathway.
NF­κB is constitutively active in most tumor
cell lines and in tumor tissues derived from
patients with various types of cancer
including breast cancer NF­κB is resides in
the cytoplasm of all cells, however when NF­
κB is being activated it will be translocated
in the nucleus and affected the downstream
gene expression. MMP9 is one of many gene
products regulated by NF­κB activation
(Aggarwal, 2004). Taken together, our
findings indicated that brazilein and that
suppression of NF­κB signaling may be
involved in the mechanism. However, further
studies are needed to clarify the molecular
mechanism underlies brazilein and its
combination in modulating cell cycle,
inducing apoptosis and inhibiting migration
and invasion in metastatic breast cancer cells.
Conclusions
This study concludes that brazilein
worked synergistically with cisplatin to
inhibit proliferation and migration in 4T1
cancer cells through inhibition of MMP9 and
Rac1 protein expression.
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